5,8,14-Triazatetracyclo[10.3.1.02.11.04,9]hexadeca-2(11),3,5,7,9-pentaene

Abstract

Compound of the formula and its pharmaceutically. acceptable salt, wherein R1 R 2 , R3 and n are defined as in the specification, intermediate in the synthesis of such compound, pharmaceutical composition containing such compound and method of using such compound in the treatment of neurological and psychological disorders are claimed.